In early 2017, House Agriculture chairman Michael Conaway was among U.S. representatives who purchased stock in the Australian biomedical company that’s at the center of insider-trading charges against New York Rep. Chris Collins. The comparatively wealthy Conaway bought shares of Innate Immunotherapeutics in January and February 2017 through a Merrill Lynch account that he owns… » Read More
The Ag Insider content is only available to members.